Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-19-034903

Chief Financial Officer bought 1,920 shares at $20.80 ($39,936)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Pizzie Nick Chief Financial Officer 2019-06-11 Purchase +1,920 $20.80 $39,936 1,920 D
Open-market purchases · 1,920 sh · avg $20.80 · $39,936
Loading xslF345X03/a4.xml…